Collagen and elasten are created by an amino acid in the body, controlled by the LOXL2 acid. Stopping the spread of breast cancer might mean obstructing the LOXL2 enzyme. About 90 percent of cancer deaths are brought on by cancer spreading from one part of the body to another.
Using enzyme blocks to work with breast cancer
In medical journal Cancer Research, researchers at the Institute of Cancer Research in the U.K. published their recent findings. Researchers put chemicals in cancer of the breast cells. This was so the LOXL2 enzyme would be blocked. Having the enzyme blockers there showed an improvement. The cancer cells didn't spread very often. The cancer that spreads quickly from breast tissue to the bloodstream is connected to LOXL2 enzymes and LOXL2 gene in the bloodstream. Death ends up being more of a possibility after cancer spreads from tissue to blood. This is because the cancer might end up reappearing anywhere in the body.
Enzymes that are LOXL2
The LOXL2 gene utilizes copper to synthesize collagen and elastin. The gene helps the body produce and rebuild. In order to get cancer to move from muscle and fat and into the blood, the enzyme is used. LOXL2 enzymes are typically present in very high amounts in individuals who have fast-spreading cancer. Stopping the spread of cancer with enzymes hasn't been tested directly on humans. It has only been used on mice. Humans have not had the LOXL2 used yet. It has not commonly been used anyway.
Creating targeted cancer drugs
Specific cancers are targeted with the research that researchers have been doing to try to cure cancer. Getting targeted cancer drugs put together can be hard to do. This is because sometimes they differ from person to person. Up to two years would be needed to get FDA approval on human LOXL2 enzyme drugs. This would be after the three years needed to make the drugs work.
Information from
HC2D
hc2d.co.uk/content.php?contentId=17644
No comments:
Post a Comment